Patients with Hashimoto's disease treated with L-thyroxine and followed for three years.
This study investigated the effectiveness of L-thyroxine management in 32 patients (mean age 11 years and 2 months; M:F = 1:5) with Hashimoto's disease followed annually for 3 years. One (8%) of the 12 patients, euthyroid at the onset, never required treatment; of the four (33%) who began treatment immediately, two were able to stop at the 1st or 2nd follow-up, whereas two had to continue. The other seven (59%) who did not begin treatment immediately had to start at the 1st, 2nd or 3rd follow-up. The findings in this small series suggest that hormone management may prove effective to a certain extent in euthyroid Hashimoto patients, primarily as a means of prevention.
Mussa
G C
GC
Department of Paediatrics, University of Turin, Italy.
Corrias
A
A
Mostert
M
M
Pellegrino
D
D
Silvestro
L
L
D000293:Adolescent; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D013967:Thyroiditis, Autoimmune / Q000188:drug therapy*; D013974:Thyroxine / Q000627:therapeutic use*
D013974:Thyroxine